Top View
- (12) Patent Application Publication (10) Pub. No.: US 2002/0010208A1 Shashoua Et Al
- WO 2016/183486 Al 17 November 2016 (17.11.2016) P O P C T
- (12) United States Patent (10) Patent No.: US 6,596,770 B2 Lai Et Al
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- (12) Patent Application Publication (10) Pub. No.: US 2010/0055072 A1 Gant Et Al
- United States Patent $835 a 88: As: Inhibitor 1-((R)-3-(4-Amino-3-(4
- (12) United States Patent (10) Patent No.: US 8,784.808 B2
- Customs Tariff - Schedule
- (12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
- ATC-Index Mit DDD-Angaben Für Den Deutschen Arzneimittelmarkt Berlin 2013, 12
- ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
- Clinical and Experimental Data on the Use of Laquinimod for the Treatment of Multiple Sclerosis
- Customs Tariff - Schedule Xxi - 1
- Australian Statistics on Medicines 2009
- Wo 2007/044693 A2
- Pdf/2009-10/Firmagon - Ct-6725.Pdf 58
- (12) United States Patent (10) Patent No.: US 9,724,338 B2 Michelson (45) Date of Patent: Aug
- WO 2017/125424 Al 27 July 2017 (27.07.2017) P O P C T
- (12) United States Patent (10) Patent No.: US 8,480,637 B2 Ferrari Et Al
- (12) United States Patent (10) Patent No.: US 8,232,265 B2 Rogers Et Al
- Rapid Immune Recovery and Graft-Versus-Host Disease ^ Like Engraftment Syndrome Following Adoptive Transfer of Costimulated Autologous T Cells Aaron P
- REVIEW a Hypothesis for the Pathogenesis of Myelodysplastic Syndromes: Implications for New Therapies
- (12) United States Patent (10) Patent No.: US 8,802,596 B2 Rogers Et Al
- 46Th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF)
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- [Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
- Neutralizing Antibodies and the Biological Response to Interferon-Beta Therapy
- Harmonized Tariff Schedule of the United States (2006) (Rev
- Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
- (19) DANMARK (1°) DK/EP 2608799 T3 (12) Oversættelse Af Europæisk Patentskrift
- Concept ID Name Class 1319998 Acebutolol Adrenergics 1154343
- (12) United States Patent (10) Patent No.: US 8,632,510 B2 Ferrari Et Al
- Roquinimex (Linomide) Vs Placebo in AML After Autologous Bone Marrow Transplantation
- ( 12 ) United States Patent
- ATC Code Title
- Immunostimulating Agents for the Prevention of Acute Otitis Media (Protocol)
- Disability Outcome Measures in Phase III Clinical Trials in Multiple Sclerosis
- Methodik Der ATC-Klassifikation Und DDD-Festlegung Für Den Deutschen